Morgan Stanley’s James Gorman stepping down as executive chair by year-end
Barron's: Hello Nvidia, Goodbye Intel? What the AI Stock’s Split Could Mean for the Dow.
Zealand Pharma Reports Low-Dose Results for New Obesity Drug
By Ben Glickman Zealand Pharma said small doses of its potential new obesity drug reduced study participants' weight by more than a placebo treatment.
Trump may be ‘positioned to win’ because swing-state voters dislike ‘Bidenomics,’ Cook Political Report says
White House race is close but presumptive Republican nominee Donald Trump appears to have the edge at the moment thanks in ...
‘Green’ tech and EVs will lead to ‘huge’ shift in metals demand, analyst says
The world’s transition toward so-called “green” technologies, such as electric vehicles and battery storage, is set to ...
MarketWatch25m
Boeing, Intel share losses lead Dow's 612-point fall
Behind declines for shares of Boeing and Intel, the Dow Jones Industrial Average is in a selloff Thursday afternoon. Shares ...
Stock Market Today: Dow drops 600 points in afternoon trade
All 30 of the Dow's components are taking part in the index's 589-point drop. The biggest drag on the Dow is Boeing's stock, ...
When it comes to Ticketmaster, Pearl Jam was decades ahead of the Justice Department
The rock band went to war with the ticketing giant in the 1990s and lost — but its argument has been vindicated, in part, by ...
Nvidia earnings: Stock charges above $1,000 as optimism builds
Could Nvidia be a $3 trillion company soon? Needham analyst N. Quinn Bolton teased the prospect in a note to clients titled: ...